ADX106772, an mGlu2 receptor positive allosteric modulator, selectively attenuates oxycodone taking and seeking
暂无分享,去创建一个
[1] G. El Fakhri,et al. Synthesis and Characterization of [18F]JNJ-46356479 as the First 18F-Labeled PET Imaging Ligand for Metabotropic Glutamate Receptor 2 , 2021, Molecular Imaging and Biology.
[2] G. Koob. Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development , 2020, Pharmacological Reviews.
[3] O. George,et al. Oxycodone self-administration and withdrawal behaviors in male and female Wistar rats , 2020, Psychopharmacology.
[4] G. Koob. Neurobiology of Opioid Addiction: Opponent Process, Hyperkatifeia, and Negative Reinforcement , 2020, Biological Psychiatry.
[5] A. Matzeu,et al. Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats , 2019, Neuropharmacology.
[6] Zhiqiang Liu,et al. Downregulation of mGluR2/3 receptors during morphine withdrawal in rats impairs mGluR2/3- and NMDA receptor-dependent long-term depression in the nucleus accumbens , 2019, Neuroscience Letters.
[7] Z. Xi,et al. Deletion of the type 2 metabotropic glutamate receptor increases heroin abuse vulnerability in transgenic rats , 2018, Neuropsychopharmacology.
[8] J. Schroeder,et al. Molecular Adaptations in the Rat Dorsal Striatum and Hippocampus Following Abstinence-Induced Incubation of Drug Seeking After Escalated Oxycodone Self-Administration , 2018, Molecular Neurobiology.
[9] K. Janda,et al. Δ9-tetrahydrocannabinol attenuates oxycodone self-administration under extended access conditions , 2017, Neuropharmacology.
[10] P. Schweitzer,et al. Dynorphin Counteracts Orexin in the Paraventricular Nucleus of the Thalamus: Cellular and Behavioral Evidence , 2017, Neuropsychopharmacology.
[11] F. Weiss,et al. Perseveration of craving: effects of stimuli conditioned to drugs of abuse versus conventional reinforcers differing in demand , 2017, Addiction biology.
[12] María Lourdes Linares,et al. Discovery of 8-Trifluoromethyl-3-cyclopropylmethyl-7-[(4-(2,4-difluorophenyl)-1-piperazinyl)methyl]-1,2,4-triazolo[4,3-a]pyridine (JNJ-46356479), a Selective and Orally Bioavailable mGlu2 Receptor Positive Allosteric Modulator (PAM). , 2016, Journal of medicinal chemistry.
[13] A. Cross,et al. The mGluR2 Positive Allosteric Modulator, AZD8529, and Cue-Induced Relapse to Alcohol Seeking in Rats , 2016, Neuropsychopharmacology.
[14] A. Cross,et al. Attenuation of nicotine-taking and nicotine-seeking behavior by the mGlu2 receptor positive allosteric modulators AZD8418 and AZD8529 in rats , 2016, Psychopharmacology.
[15] Y. Shaham,et al. The Novel Metabotropic Glutamate Receptor 2 Positive Allosteric Modulator, AZD8529, Decreases Nicotine Self-Administration and Relapse in Squirrel Monkeys , 2015, Biological Psychiatry.
[16] G. Schoenbaum,et al. Effect of the Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor 2 AZD8529 on Incubation of Methamphetamine Craving After Prolonged Voluntary Abstinence in a Rat Model , 2015, Biological Psychiatry.
[17] A. Haghparast,et al. Blockage of acquisition and expression of morphine-induced conditioned place preference in rats due to activation of glutamate receptors type II/III in nucleus accumbens , 2015, Pharmacology Biochemistry and Behavior.
[18] P. Kalivas,et al. Synaptic Glutamate Spillover Due to Impaired Glutamate Uptake Mediates Heroin Relapse , 2014, The Journal of Neuroscience.
[19] R. Spanagel,et al. Rescue of Infralimbic mGluR2 Deficit Restores Control Over Drug-Seeking Behavior in Alcohol Dependence , 2013, The Journal of Neuroscience.
[20] Nirmal Singh,et al. Opioid withdrawal syndrome: emerging concepts and novel therapeutic targets. , 2013, CNS & neurological disorders drug targets.
[21] Joseph P. Schacht,et al. Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta‐analysis and systematic review , 2013, Addiction biology.
[22] Zhiqiang Liu,et al. Potentiation of synaptic strength and intrinsic excitability in the nucleus accumbens after 10 days of morphine withdrawal , 2012, Journal of neuroscience research.
[23] J. Widholm,et al. Alcohol‐seeking behavior is associated with increased glutamate transmission in basolateral amygdala and nucleus accumbens as measured by glutamate‐oxidase‐coated biosensors , 2011, Addiction biology.
[24] P. Kalivas,et al. Group II metabotropic glutamate receptors (mGlu2/3) in drug addiction. , 2010, European journal of pharmacology.
[25] D. Sheffler,et al. The mGluR2 Positive Allosteric Modulator BINA Decreases Cocaine Self-Administration and Cue-Induced Cocaine-Seeking and Counteracts Cocaine-Induced Enhancement of Brain Reward Function in Rats , 2010, Neuropsychopharmacology.
[26] R. LaLumiere,et al. Glutamate transmission in addiction , 2009, Neuropharmacology.
[27] P. Kalivas. The glutamate homeostasis hypothesis of addiction , 2009, Nature Reviews Neuroscience.
[28] Xiao-Hui Xiang,et al. The role of glutamate and its receptors in mesocorticolimbic dopaminergic regions in opioid addiction , 2009, Neuroscience & Biobehavioral Reviews.
[29] F. Weiss,et al. Dissociation of the Effects of MTEP [3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]piperidine] on Conditioned Reinstatement and Reinforcement: Comparison between Cocaine and a Conventional Reinforcer , 2009, Journal of Pharmacology and Experimental Therapeutics.
[30] P. Phillips,et al. Phasic dopamine release in appetitive behaviors and drug addiction. , 2009, Current drug abuse reviews.
[31] M. Liechti,et al. Metabotropic Glutamate 2/3 Receptors in the Ventral Tegmental Area and the Nucleus Accumbens Shell Are Involved in Behaviors Relating to Nicotine Dependence , 2007, The Journal of Neuroscience.
[32] F. Kobarfard,et al. Sex differences and role of gonadal hormones on glutamate level in the nucleus accumbens in morphine tolerant rats: a microdialysis study. , 2007, European journal of pharmacology.
[33] N. Volkow,et al. The neural basis of addiction: a pathology of motivation and choice. , 2005, The American journal of psychiatry.
[34] J. Seamans,et al. Cystine/Glutamate Exchange Regulates Metabotropic Glutamate Receptor Presynaptic Inhibition of Excitatory Transmission and Vulnerability to Cocaine Seeking , 2005, The Journal of Neuroscience.
[35] Chunfu Wu,et al. Morphine decreases extracellular levels of glutamate in the anterior cingulate cortex: an in vivo microdialysis study in freely moving rats , 2005, Brain Research.
[36] S. Nakanishi,et al. Enhanced cocaine responsiveness and impaired motor coordination in metabotropic glutamate receptor subtype 2 knockout mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[37] N. Volkow,et al. Unmanageable Motivation in Addiction: A Pathology in Prefrontal-Accumbens Glutamate Transmission , 2005, Neuron.
[38] Gary Aston-Jones,et al. Brain substrates for increased drug seeking during protracted withdrawal , 2004, Neuropharmacology.
[39] G. Barr,et al. The role of AMPA and metabotropic glutamate receptors on morphine withdrawal in infant rats , 2004, International Journal of Developmental Neuroscience.
[40] F. Weiss,et al. Preferential Effects of the Metabotropic Glutamate 2/3 Receptor Agonist LY379268 on Conditioned Reinstatement versus Primary Reinforcement: Comparison between Cocaine and a Potent Conventional Reinforcer , 2004, The Journal of Neuroscience.
[41] P. Kenny,et al. The ups and downs of addiction: role of metabotropic glutamate receptors. , 2004, Trends in pharmacological sciences.
[42] J. Fiez,et al. Prefrontal responses to drug cues: a neurocognitive analysis , 2004, Nature Neuroscience.
[43] P. Kalivas,et al. Glutamate systems in cocaine addiction. , 2004, Current opinion in pharmacology.
[44] J. Sepúlveda,et al. Neurochemical changes of the extracellular concentrations of glutamate and aspartate in the nucleus accumbens of rats after chronic administration of morphine. , 2004, European journal of pharmacology.
[45] J. Stewart,et al. A role for the prefrontal cortex in stress- and cocaine-induced reinstatement of cocaine seeking in rats , 2003, Psychopharmacology.
[46] P. Kalivas,et al. Prefrontal Glutamate Release into the Core of the Nucleus Accumbens Mediates Cocaine-Induced Reinstatement of Drug-Seeking Behavior , 2003, The Journal of Neuroscience.
[47] David Robbe,et al. Metabotropic glutamate receptor 2/3‐dependent long‐term depression in the nucleus accumbens is blocked in morphine withdrawn mice , 2002, The European journal of neuroscience.
[48] Z. Bashir,et al. Cooperation between mglu receptors: a depressing mechanism? , 2002, Trends in Neurosciences.
[49] J. Pin,et al. The metabotropic glutamate receptors: structure, activation mechanism and pharmacology. , 2002, Current drug targets. CNS and neurological disorders.
[50] K. Berridge,et al. The Neuroscience of Natural Rewards: Relevance to Addictive Drugs , 2002, The Journal of Neuroscience.
[51] P. Kalivas,et al. The Circuitry Mediating Cocaine-Induced Reinstatement of Drug-Seeking Behavior , 2001, The Journal of Neuroscience.
[52] B. Everitt,et al. Dissociable Effects of Antagonism of NMDA and AMPA/KA Receptors in the Nucleus Accumbens Core and Shell on Cocaine-seeking Behavior , 2001, Neuropsychopharmacology.
[53] T L Faber,et al. Neural activity related to drug craving in cocaine addiction. , 2001, Archives of general psychiatry.
[54] T. Tzschentke. Pharmacology and behavioral pharmacology of the mesocortical dopamine system , 2001, Progress in Neurobiology.
[55] D. Schoepp,et al. Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors , 2000, Journal of neurochemistry.
[56] P. Kalivas,et al. Glutamate Transmission in the Nucleus Accumbens Mediates Relapse in Cocaine Addiction , 2000, The Journal of Neuroscience.
[57] P. Kalivas,et al. A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior , 1999, Neuroscience.
[58] C. Heyser,et al. Differential expression of response-disruptive and somatic indices of opiate withdrawal during the initiation and development of opiate dependence. , 1999, Behavioural pharmacology.
[59] G F Koob,et al. Drug abuse: hedonic homeostatic dysregulation. , 1997, Science.
[60] K. A. Haberny,et al. Interactive effects of MK-801 and morphine on EEG, EEG power spectra and behavior in rats: I. Morphine tolerance development. , 1994, European journal of pharmacology.
[61] S. B. Caine,et al. Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. , 1993, Science.
[62] F. Bloom,et al. Cellular and molecular mechanisms of drug dependence. , 1988, Science.
[63] H. Bradford,et al. Suppression of evoked and spontaneous release of neurotransmitters in vivo by morphine. , 1980, Biochemical pharmacology.
[64] W. Zieglgänsberger,et al. A DEMONSTRATION OF NALOXONE‐PRECIPITATED OPIATE WITHDRAWAL ON SINGLE NEURONES IN THE MORPHINE‐TOLERANT/DEPENDENT RAT BRAIN , 1980, British journal of pharmacology.
[65] H. Loh,et al. Quantitative aspects of precipitated abstinence in morphine-dependent rats. , 1973, The Journal of pharmacology and experimental therapeutics.
[66] G. Koob,et al. Compulsive-Like Responding for Opioid Analgesics in Rats with Extended Access , 2015, Neuropsychopharmacology.
[67] M. Olive,et al. Glutamatergic substrates of drug addiction and alcoholism. , 2008, Biochemical pharmacology.
[68] P. Kalivas,et al. Drug Addiction as a Pathology of Staged Neuroplasticity , 2008, Neuropsychopharmacology.
[69] W. Zieglgänsberger,et al. Supersensitivity of cortical neurones of the rat to acetylcholine and L-glutamate following chronic morphine treatment , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.
[70] G. Siggins,et al. Chronic morphine treatment selectively augments metabotropic glutamate receptor-induced inhibition of N-methyl-D-aspartate receptor-mediated neurotransmission in nucleus accumbens. , 1999, The Journal of pharmacology and experimental therapeutics.